Your fact-checks will appear here
A 2023 study by Khan et al. on the effects of daily honey consumption on cognitive function in older adults, as reported in the Journal of Nutrition, Health & Aging.
A growing body of laboratory and animal research reports that honey and honey-derived compounds have antioxidant, anti-inflammatory and anti-amyloid properties that could, in principle, protect brain ...
Randomized controlled trials and systematic reviews indicate that Bacopa monnieri produces modest, domain‑specific cognitive benefits—particularly in attention, processing speed, and some memory tests...
Clinical research to date does not provide robust, conclusive evidence that honey prevents or reverses cognitive decline in humans: the bulk of scientific data are preclinical—cell and animal studies—...
Peer-reviewed preclinical research—cell culture and many animal studies—consistently shows honey and isolated honey-derived polyphenols exert antioxidant, anti-inflammatory and anti-amyloid effects th...
Neither large randomized controlled trials nor registered clinical programs specifically testing honey or broader apitherapy as a disease‑modifying treatment for Alzheimer’s disease (AD) exist in the ...
Honey contains a complex mix of polyphenols, flavonoids and sugars that in preclinical studies act on multiple biological pathways implicated in cognitive decline—chiefly by reducing oxidative stress,...
A 2023 randomized controlled trial by Khan et al., published in the Journal of Nutrition, Health & Aging and reported in secondary coverage, concluded that daily honey consumption “improves cognitive ...